Wolverine Trading’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$581K Sell
74,800
-20,100
-21% -$141K ﹤0.01% 3532
2025
Q2
$681K Buy
94,900
+62,900
+197% +$508K ﹤0.01% 2664
2025
Q1
$308K Buy
+32,000
New +$400K ﹤0.01% 3492
2022
Q4
Sell
-10,600
Closed -$92K 4684
2022
Q3
$92K Sell
10,600
-1,400
-12% -$13.9K ﹤0.01% 3952
2022
Q2
$100K Buy
12,000
+200
+2% +$1.91K ﹤0.01% 3849
2022
Q1
$153K Buy
11,800
+5,300
+82% +$112K ﹤0.01% 4593
2021
Q4
$222K Buy
+6,500
New +$255K ﹤0.01% 4556
2019
Q4
Sell
-14,500
Closed -$277K 5005
2019
Q3
$277K Buy
+14,500
New +$340K ﹤0.01% 3251
2019
Q2
Sell
-9,900
Closed -$203K 4893
2019
Q1
$203K Sell
9,900
-9,300
-48% -$162K ﹤0.01% 3808
2018
Q4
$233K Sell
19,200
-400
-2% -$5.96K ﹤0.01% 3523
2018
Q3
$301K Buy
+19,600
New +$271K ﹤0.01% 3728
2016
Q4
Sell
-24,700
Closed -$198K 4896
2016
Q3
$198K Buy
+24,700
New +$207K ﹤0.01% 3837

Other funds holding NEO

Wolverine Trading's NEO Position: Q4 2019 in Review

Wolverine Trading sold out of NeoGenomics (NEO) in Q4 2019, closing a stake of 21,252 shares — an estimated $406K sold.

Wolverine Trading first reported a position in NEO in Q3 2019 and held it in 1 quarter. The position peaked at $406K in Q3 2019. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

  • Wolverine Trading reported no remaining NeoGenomics position as of Q4 2019 after selling out during the quarter.
  • Wolverine Trading sold 21,252 NeoGenomics shares in Q4 2019, an estimated $406K.
  • Wolverine Trading first reported a position in NeoGenomics in Q3 2019 and held it in 1 quarter.
  • Wolverine Trading's NeoGenomics position peaked at $406K in Q3 2019.
  • 261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.